(Cilostazol + rosuvastatin) is under clinical development by Korea United Pharm and currently in Phase I for Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). According to GlobalData, ...
In a large, long-term trial, cilostazol was as effective as aspirin at preventing recurrent stroke and was associated with fewer hemorrhages. Antiplatelet drugs have an established role in ...
We examined the effects of cilostazol, a quinolone derivative, on HR and HR variability in patients with sick sinus syndrome. Design: Non-blind sequential single-group study. Patients: 12 patients ...